Role of Genetic Factors in the Development of Lung Disease

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 399 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Re-verified, no change to tracked fields
  3. New version filed on ClinicalTrials.gov
  4. 47 versions Re-verified since Sep 20, 2024, no change to tracked fieldsv350-v396
This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examining the genes in lung cells of patients with lung disease. The study will focus on defining the distribution of abnormal genes responsible for processes directly involved in different diseases affecting the lungs of patients and healthy volunteers. Optional CT Sub-study The standard CT scan will be compared to the low dose radiation CT scan for the 150 subjects enrolled in the sub-study to assess the variation between the two techniques. Specifically, the quantitative computer aided detection of lung CT abnormalities from LAM can be compared to assess whether low radiation dose CT exams is an alternative to conventional CT to monitor disease status. This optional sub-study will be offered to up to 100 adult subjects with lung disease and up to 50 children age 9 and older with CF. Children will not be enrolled in the optional CT sub-study unless they have had a standard CT scan for medical purposes to use in comparison. One additional low dose radiation CT scan of the chest may be done as part of this sub-study when these subjects have their next annual CT scan....
Trial Details
NCT Number NCT00001532
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Collaborators: Suburban Hospital
Conditions
(from sponsor)
Cystic Fibrosis, Pulmonary Fibrosis, Tuberous Sclerosis, Asthma, Pulmonary Sarcoidosis
Related terms alpha 1-Antitrypsin Deficiency, Asthma, Cystic Fibrosis, Lung Diseases, Pulmonary Fibrosis, Sarcoidosis, Pulmonary, Tuberous Sclerosis
Enrollment 3,500 participants
Start Date
Updated on ClinicalTrials.gov